Shares of Intuitive Surgical Inc. advanced 7.65% to $580.11 Wednesday, on what proved to be an all-around positive trading ...

Medicare may begin to cover renal denervation with Medtronic’s Symplicity device by October, which could drive coverage among ...

Clinical obesity -- now defined as a state of ongoing illness -- is hallmarked by reduced tissue or organ function due to ...

The Centers for Medicare & Medicaid Services will review a potential national Medicare coverage policy for renal denervation ...

In diabetes care, the MiniMed 780G insulin pump system uses AI algorithms to predict and adjust insulin delivery based on ...

The stock's fall snapped a two-day winning streak.

Cardiac device innovations made waves in 2024, with regulatory approvals, clinical breakthroughs, and product launches ...

Medtronic says CMS is opening a national coverage analysis on renal denervation (RDN) procedures for patients with ...

Medtronic Vietnam and the University Medical Center Ho Chi Minh City (UMC HCMC) have signed their fourth Memorandum of ...

While deep-brain stimulation therapy has been available for people with Parkinson’s disease for decades, Medtronic has now ...

New technologies for atrial fibrillation, hypertension, diabetes and neurological conditions are poised for fast growth, Martha said Monday at the J.P. Morgan Healthcare Conference.

Analyst Travis Steed of Bank of America Securities maintained a Buy rating on Medtronic (MDT – Research Report), retaining the price target of ...